Pharvaris
5 known investors
Find your way into Pharvaris
Sign up to see every warm intro you have to Pharvaris
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Pharvaris team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Pharvaris develops investigational oral therapies for people living with bradykinin-mediated angioedema. It is a clinical-stage biopharmaceutical company focused on this rare disease area.
Investors · 5
How we know: Bain Capital Life Sciences's portfolio page · Not right? Tell us
How we know: Foresite Capital's portfolio page · a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Kurma Partners's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: venBio Partners's portfolio page · a partner's Signal profile · the VCSheet dataset · Not right? Tell us
Founder mafia
2 people who came through Pharvaris went on to found or lead other companies.
Frequently asked questions
- What does Pharvaris do?
- Pharvaris develops investigational oral therapies for people living with bradykinin-mediated angioedema. It is a clinical-stage biopharmaceutical company focused on this rare disease area.
- Who are Pharvaris's investors?
- Pharvaris's investors include Bain Capital Life Sciences, Foresite Capital, Kurma Partners, venBio Partners, Viking Global.



